216 related articles for article (PubMed ID: 23838753)
1. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD
Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753
[TBL] [Abstract][Full Text] [Related]
2. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
[TBL] [Abstract][Full Text] [Related]
5. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
[TBL] [Abstract][Full Text] [Related]
6. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI
J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
[TBL] [Abstract][Full Text] [Related]
8. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
[TBL] [Abstract][Full Text] [Related]
9. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
10. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
[TBL] [Abstract][Full Text] [Related]
11. The Combination of Clinical Features, Transcranial Doppler, and Alberta Stroke Program Early Computed Tomography Score (Computed Tomography Angiography) in Predicting Outcome in Intravenous Recombinant Tissue Plasminogen Activator-Treated Patients.
Saqqur M; Ghrooda E; Ahmad A; Khan K; Hussain MS; Shuaib A
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2019-23. PubMed ID: 27241578
[TBL] [Abstract][Full Text] [Related]
12. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
IMS Study Investigators
Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
[TBL] [Abstract][Full Text] [Related]
13. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
14. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
15. Googling Stroke ASPECTS to Determine Disability: Exploratory Analysis from VISTA-Acute Collaboration.
Beare R; Chen J; Phan TG;
PLoS One; 2015; 10(5):e0125687. PubMed ID: 25961856
[TBL] [Abstract][Full Text] [Related]
16. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke.
Hong KS; Saver JL
Stroke; 2010 Mar; 41(3):471-7. PubMed ID: 20133917
[TBL] [Abstract][Full Text] [Related]
17. Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.
Balucani C; Levine SR; Khoury JC; Khatri P; Saver JL; Broderick JP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):894-901. PubMed ID: 26825352
[TBL] [Abstract][Full Text] [Related]
18. Mild stroke: safety and outcome in patients receiving thrombolysis.
Logallo N; Kvistad CE; Naess H; Waje-Andreassen U; Thomassen L
Acta Neurol Scand Suppl; 2014; (198):37-40. PubMed ID: 24588505
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.
Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2018 Jun; 49(6):1407-1411. PubMed ID: 29777016
[TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
